Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M. A. Libonati"'
Autor:
Najara Carneiro Bittencourt, Ana Beatriz Iung Enembreck da Silva, Natália Silveira Virgili, Ana Paula Schappo, João Henrique D B Gervásio, Tamirys S Pimenta, Mario A Kujbida Junior, Ana Maria R S Ventura, Rosana M F Libonati, João Luiz Silva-Filho, Hellen Geremias Dos Santos, Stefanie C P Lopes, Marcus V G Lacerda, Ricardo L D Machado, Fabio T M Costa, Letusa Albrecht
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 14, Iss 7, p e0008471 (2020)
In Brazil, Plasmodium vivax infection accounts for around 80% of malaria cases. This infection has a substantial impact on the productivity of the local population as the course of the disease is usually prolonged and the development of acquired immu
Externí odkaz:
https://doaj.org/article/f89974d1de724abe942bca85840a3a75
Autor:
Timothy Vollmer, William A. Sheremata, Paul O'Connor, A. J. Willmer-Hulme, Andrew D. Goodman, M. A. Libonati, Luanne M. Metz, Lael Stone, R. S. Murray
Publikováno v:
Neurology. 62:2038-2043
Relapses in multiple sclerosis (MS) can cause significant neurologic disability. Natalizumab (Antegren) is a humanized anti-alpha4-integrin antibody that inhibits the trafficking of leukocytes across endothelium by blocking binding of alpha4beta1-int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a769b06cab6874c33169777c7eae255
https://doi.org/10.1212/01.wnl.0000128136.79044.d6
https://doi.org/10.1212/01.wnl.0000128136.79044.d6
Autor:
Andrew D. Goodman, J. S. Grundy, Timothy Vollmer, J. L. Giacchino, Mark A. Agius, M. A. Libonati, J. T. Phillips
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 10(5)
In this open-label drug-interaction trial, we studied 38 patients with relapsing-remitting multiple sclerosis (MS) who received 3.0 or 6.0 mg/kg of natalizumab as a single intravenous (IV) infusion during stable treatment with intramuscular (IM) inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d89e78a6c4da915ab68359931fce31cb
https://pubmed.ncbi.nlm.nih.gov/15471366
https://pubmed.ncbi.nlm.nih.gov/15471366
Autor:
M M, Libonati
Publikováno v:
Journal of ophthalmic nursingtechnology. 5(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::487d29602df016ff262e0bf0d331c517
https://pubmed.ncbi.nlm.nih.gov/2428982
https://pubmed.ncbi.nlm.nih.gov/2428982